Population-based laboratory surveillance for Serratia species isolates in a large Canadian health region
A population-based laboratory surveillance was conducted during a six-year period to define the incidence, demographic risk factors for acquisition, and anti-microbial susceptibilities of Serratia species isolates. A total of 715 incident Serratia species isolates were identified for an annual incidence of 10.8 per 100,000 residents; bacteremic disease occurred in 0.9 per 100,000 residents annually. The incidence increased with advancing age and males were at the highest risk. Ninety-two percent of the isolates were Serratia marcescens, and the majority (65%) of incident Serratia species isolates were of community onset. Ninety-five percent of isolates were susceptible to ciprofloxacin, 98% to gentamicin, 98% to trimethoprim/sulfamethoxazole, and >99% to imipenem. No yearly increase in resistance was observed. Serratia species isolation is most commonly of community onset and older patients and males are at increased risk. Despite reports of increasing resistance among Serratia species, the incidence in our region remains at a low stable rate.
KeywordsSerratia Marcescens Urinary Tract Obstruction Demographic Risk Factor Calgary Health Region Serratia Species
No external financial support was obtained for this study. None of the authors had financial, professional, or personal competing interests that would influence the conduct or reporting of this study.
- 2.Yoon HJ, Choi JY, Park YS, Kim CO, Kim JM, Yong DE, Lee KW, Song YG (2005) Outbreaks of Serratia marcescens bacteriuria in a neurosurgical intensive care unit of a tertiary care teaching hospital: a clinical, epidemiologic, and laboratory perspective. Am J Infect Control 33(10):595–601PubMedCrossRefGoogle Scholar
- 4.Su L-H, Ou JT, Leu H-S, Chiang P-C, Chiu Y-P, Chia J-H, Kuo A-J, Chiu C-H, Chu C, Wu T-L, Sun C-F, Riley TV, Chang BJ; The Infection Control Group (2003) Extended epidemic of nosocomial urinary tract infections caused by Serratia marcescens. J Clin Microbiol 41(10):4726–4732PubMedCrossRefGoogle Scholar
- 5.Casolari C, Pecorari M, Fabio G, Cattani S, Venturelli C, Piccinini L, Tamassia MG, Gennari W, Sabbatini AM, Leporati G, Marchegiano P, Rumpianesi F, Ferrari F (2005) A simultaneous outbreak of Serratia marcescens and Klebsiella pneumoniae in a neonatal intensive care unit. J Hosp Infect 61(4):312–320PubMedCrossRefGoogle Scholar
- 9.Bagattini M, Crispino M, Gentile F, Barretta E, Schiavone D, Boccia MC, Triassi M, Zarrilli R (2004) A nosocomial outbreak of Serratia marcescens producing inducible Amp C-type beta-lactamase enzyme and carrying antimicrobial resistance genes within a class 1 integron. J Hosp Infect 56(1):29–36PubMedCrossRefGoogle Scholar
- 10.Horcajada JP, Martinez JA, Alcón A, Marco F, De Lazzari E, de Matos A, Zaragoza M, Sallés M, Zavala E, Mensa J (2006) Acquisition of multidrug-resistant Serratia marcescens by critically ill patients who consumed tap water during receipt of oral medication. Infect Control Hosp Epidemiol 27(7):774–777PubMedCrossRefGoogle Scholar
- 11.Uduman SA, Farrukh AS, Nath KN, Zuhair MY, Ifrah A, Khawla AD, Sunita P (2002) An outbreak of Serratia marcescens infection in a special-care baby unit of a community hospital in United Arab Emirates: the importance of the air conditioner duct as a nosocomial reservoir. J Hosp Infect 52(3):175–180PubMedCrossRefGoogle Scholar
- 25.Schuchat A, Hilger T, Zell E, Farley MM, Reingold A, Harrison L, Lefkowitz L, Danila R, Stefonek K, Barrett N, Morse D, Pinner R; Active Bacterial Core Surveillance Team of the Emerging Infections Program Network (2001) Active bacterial core surveillance of the emerging infections program network. Emerg Infect Dis 7(1):92–99PubMedCrossRefGoogle Scholar
- 28.Friedman ND, Kaye KS, Stout JE, McGarry SA, Trivette SL, Briggs JP, Lamm W, Clark C, MacFarquhar J, Walton AL, Reller LB, Sexton DJ (2002) Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med 137(10):791–797PubMedGoogle Scholar
- 31.Laupland KB, Parkins MD, Church DL, Gregson DB, Louie TJ, Conly JM, Elsayed S, Pitout JD (2005) Population-based epidemiological study of infections caused by carbapenem-resistant Pseudomonas aeruginosa in the Calgary Health Region: importance of metallo-beta-lactamase (MBL)-producing strains. J Infect Dis 192(9):1606–1612PubMedCrossRefGoogle Scholar
- 33.Gilbert M, MacDonald J, Gregson D, Siushansian J, Zhang K, Elsayed S, Laupland K, Louie T, Hope K, Mulvey M, Gillespie J, Nielsen D, Wheeler V, Louie M, Honish A, Keays G, Conly J (2006) Outbreak in Alberta of community-acquired (USA300) methicillin-resistant Staphylococcus aureus in people with a history of drug use, homelessness or incarceration. CMAJ 175(2):149–154PubMedGoogle Scholar